Value of U.S. and EU biotech IPOs, January-October 2017
Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)
This statistic shows the value of select EU and U.S. biotech companies initial public offerings (IPOs) as reported between January and October 2017. According to the report, Biohaven Pharmaceutical Holding Company had a IPO valued at 193.5 million U.S. dollars.
Value of U.S. and European biotech initial public offerings (IPOs) in January-October 2017 (in million U.S. dollars)
Source
More information
Statistics on "Biotech industry"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- U.S. infectious disease company IPOs 2006-2017
- U.S. psychiatry company IPO financing 2006-2017
- U.S. infectious disease company IPO financing 2006-2017
- U.S. number of IPOs for neurology companies 2006-2017
- Money raised through U.S. neurology company IPOs 2006-2017
- U.S. cardiovascular company IPOs 2006-2017
- U.S. oncology company IPOs 2006-2017
- U.S. psychiatry company IPOs 2006-2017
- U.S. cardiovascular company IPO financing volume 2006-2017
- Overseas IPO volume of Chinese companies 2015, by sector
- Value of domestic IPOs in South Africa 2014-2021
- VC-backed companies in South Korea 2011-2015
- Largest initial public offerings (IPO) in the United States 2012
- Domestic IPOs of Chinese companies in China 2016, by sector
- Value of domestic IPOs in Nigeria 2014-2021
- Total value of initial public offerings (IPOs) in Europe 2008-Q3 2017
- Private security activities revenue in Malta 2010-2022
- Capacity of Acciona SWRO desalination plants in Europe in 2017, by country
- Area covered by forest in Romania 1990-2016
Statistics on "Biotech industry"
Related topics
About Statista
